Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma. - Cook TA; Jayamanne DT; Wheeler HR; Wong MHF; Parkinson JF; Cook RJ; Kastelan MA; Cove NJ; Brown C; Back MF (Neuro-oncology practice, 2021)